TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer
Conditions: Oropharynx Cancer; Squamous Cell Carcinoma of the Oral CavityIntervention: Drug: Taxotere, Cisplatin, 5-Fluorouracil (5-FU)Sponsor: Orlando Guntinas-Lichius, Prof. Dr. med.Active, not recruiting - verified October 2009
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Docetaxel | Mouth Cancer | Oral Cancer | Oropharyngeal Cancer | Research | Taxotere